A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants

NCT06213506 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

516

Enrollment

INDUSTRY

Sponsor class

Conditions

Salmonella Infections

Interventions

BIOLOGICAL: Measles and Rubella vaccine
BIOLOGICAL: Yellow Fever vaccine
BIOLOGICAL: Pentavalent vaccine
BIOLOGICAL: Pneumococcal vaccine
BIOLOGICAL: Inactivated polio vaccine
BIOLOGICAL: iNTS-GMMA Dose C
BIOLOGICAL: iNTS-GMMA Dose B
BIOLOGICAL: iNTS-GMMA Dose A
BIOLOGICAL: MenACWY
COMBINATION_PRODUCT: DTPa-HBV-IPV+Hib
DRUG: Placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]
[object Object]
[object Object]